Psychedelia.dk

Velkommen til psychedelia.dk. Vi er Danmarks største community for fornuftig anvendelse af rusmidler og legalisering.
Dato og tid er 01 aug 2021 03:38


Alle tider er UTC + 1 time [DST ]




Skriv nyt emne Svar på emne  [ 1 indlæg ] 
Forfatter besked
Indlæg: 09 feb 2021 00:43 
Offline
Admin
Brugeravatar

Tilmeldt: 25 maj 2005 23:45
Indlæg: 2455
Geografisk sted: Inside the animal
Citat:
Background
Scientific and anecdotal evidence suggest that whole plant cannabis extracts are effective in reducing seizure frequency in individuals with a range of epileptic etiologies. We report a case series of 10 individuals using CBMPs in the UK to treat their conditions.

Methods
In this retrospective study, we report on patients (aged 2-48) with severe, intractable, childhood onset epilepsies using combined cannabinoid therapy. Carers of patients provided details through the charity ‘End our Pain’ and these data were subsequently analysed. Our primary objective was to assess changes in monthly seizure frequency pre and post initiation of CBMPs. We also report on previous and current AED, CBD:THC daily dose, quality of life and financial costs associated with CBMP private prescription. Change in monthly seizure frequency were assessed using a Wilcoxon Signed-ranks test.

Results
Of the 10 patients enrolled in the study there was an 97% mean reduction in monthly seizure frequency post initiation of CBMPs which was statistically significant (Z = 0, p < 0·01). We showed a reduction in AED use following initiation of CBMPs from a mean of 8 (±5·98) to 1 (±1·05). All patients were using either Bedrolite or Bedica (Bedrocan International) as their CBMP. Individual daily doses of THC ranged from 6·6mg – 26·5mg and for CBD, 200 mg – 550 mg. Average monthly cost of CBMP was £1816·20.

Interpretation
Our findings suggest a combination of CBD and THC based products are effective in reducing seizure frequency in a range of epileptic conditions. We highlight the inefficacy of the healthcare system in supporting these patients who bare great personal and financial burdens. We encourage specialist physicians and relevant bodies to permit greater ease of access of these medications to those patients where efficacy has been shown.

Der er full text på https://journals.sagepub.com/doi/full/1 ... 4520974487

_________________
- Spis ild
Støt Psychedelia
Psychedelia.dk på facebook


Top
 Profil  
 
Vis indlæg fra foregående:  Sorter efter  
Skriv nyt emne Svar på emne  [ 1 indlæg ] 

Alle tider er UTC + 1 time [DST ]


Hvem er online

Brugere der læser dette forum: Ingen og 2 gæster


Du kan ikke skrive nye emner
Du kan ikke besvare emner
Du kan ikke redigere dine indlæg
Du kan ikke slette dine indlæg

Søg efter:
Hop til:  
Powered by phpBB® Forum Software © phpBB Group
Danish translation & support by Olympus DK Team